Buscar
Congreso SOLACI
Home Tags Atrial fibrillation

Tag: atrial fibrillation

Recently Diagnosed Atrial Fibrillation in Patients with Acute Coronary Syndrome: Results...

Dr. Carlos Fava - 0
El cierre de orejuela es seguro con los nuevos dispositivos

Evolution of Leak in Left Atrial Appendage Closure

solaci - 0
El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure: As Effective in Men and Women?

solaci - 0
Miocardiopatía hipertrófica: análisis de una serie histórica

Do Short- and Long-Term Results of Left Atrium Appendage Closure Differ...

solaci - 0
El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure Is a Valid Option

solaci - 0
Highlights TCT 2019

TCT 2019 | AUGUSTUS ACS: Apixaban vs. Warfarin and Aspirin vs....

solaci - 0

Heart and Brain: Risk Factors, Atrial Fibrillation and Dementia

solaci - 0
Mejoras tecnológicas en las válvulas que se traducen en resultados clínicos

New Percutaneous Devices to Prevent Embolism in Atrial Fibrillation

solaci - 0
TCT 2018 | OAC-ALONE: solo anticoagulación luego del año de un stent en pacientes fibrilados

TCT 2018 | OAC-ALONE: Anticoagulation Alone 1 Year After Stenting in Patients with...

solaci - 0

NSAIDs and Risk of Bleeding in Patients with Atrial Fibrillation

solaci - 0
123Page 1 of 3

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad